These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10825645)

  • 1. Spinal CSF from rats with painful peripheral neuropathy evokes catecholamine release from chromaffin cells in vitro.
    Hentall ID; Sagen J
    Neurosci Lett; 2000 Jun; 286(2):95-8. PubMed ID: 10825645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of allodynia by intrathecal transplantation of microencapsulated porcine chromaffin cells.
    Kim YM; Kwak KH; Lim JO; Baek WY
    Artif Organs; 2009 Mar; 33(3):240-9. PubMed ID: 19245523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrapeptides on N- and C-terminal regions of mastoparan inhibit catecholamine release from chromaffin cells by blocking nicotinic acetylcholine receptor.
    Monoi N; Usui M; Takahashi S; Ito H; Kumakura K; Kasai H
    Cell Mol Neurobiol; 2004 Feb; 24(1):37-50. PubMed ID: 15049509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury.
    Hains BC; Chastain KM; Everhart AW; McAdoo DJ; Hulsebosch CE
    Exp Neurol; 2000 Aug; 164(2):426-37. PubMed ID: 10915581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the functional subunit combination of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
    Tachikawa E; Mizuma K; Kudo K; Kashimoto T; Yamato S; Ohta S
    Neurosci Lett; 2001 Oct; 312(3):161-4. PubMed ID: 11602335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
    Brindley RL; Bauer MB; Hartley ND; Horning KJ; Currie KPM
    J Neurochem; 2017 Oct; 143(2):171-182. PubMed ID: 28815595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors.
    Free RB; McKay DB
    Brain Res; 2001 Feb; 891(1-2):176-84. PubMed ID: 11164821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
    Caban AJ; Hama AT; Lee JW; Sagen J
    Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial characterization of the transplant of immortalized chromaffin cells for the attenuation of chronic neuropathic pain.
    Eaton MJ; Martinez M; Karmally S; Lopez T; Sagen J
    Cell Transplant; 2000; 9(5):637-56. PubMed ID: 11144961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic stimulation of catecholamine synthesis and tyrosine hydroxylase phosphorylation in cervine adrenal medullary chromaffin cells.
    Knowles PJ; Douglas SA; Bunn SJ
    J Neuroendocrinol; 2011 Mar; 23(3):224-31. PubMed ID: 21121973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by pregnenolone sulfate of nicotinic acetylcholine response in adrenal chromaffin cells.
    Kudo K; Tachikawa E; Kashimoto T
    Eur J Pharmacol; 2002 Dec; 456(1-3):19-27. PubMed ID: 12450565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of P2X3 and P2X7 Receptors and TRPV1 Channels in Adrenomedullary Chromaffin Cells in a Rat Model of Neuropathic Pain.
    Arribas-Blázquez M; Olivos-Oré LA; Barahona MV; Sánchez de la Muela M; Solar V; Jiménez E; Gualix J; McIntosh JM; Ferrer-Montiel A; Miras-Portugal MT; Artalejo AR
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine structure of host-graft relationships between transplanted chromaffin cells and CNS.
    Pappas GD
    FASEB J; 1999 Dec; 13 Suppl 2():S277-80. PubMed ID: 10619143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space.
    Hama AT; Sagen J
    Brain Res; 1994 Jul; 651(1-2):183-93. PubMed ID: 7922566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal medullary transplants reduce formalin-evoked c-fos expression in the rat spinal cord.
    Siegan JB; Herzberg U; Frydel BR; Sagen J
    Brain Res; 2002 Jul; 944(1-2):174-83. PubMed ID: 12106677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release.
    Schneider AS; Nagel JE; Mah SJ
    Eur J Pharmacol; 1996 Dec; 317(2-3):R1-2. PubMed ID: 8997631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal xenogeneic chromaffin cell grafts reduce nociceptive behavior in a rodent tonic pain model.
    Sol JC; Sallerin B; Larrue S; Li RY; Jozan S; Tortosa F; Mascott C; Carraoue F; Tafani M; Lazorthes Y
    Exp Neurol; 2004 Apr; 186(2):198-211. PubMed ID: 15026256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine enhances Ca2+ entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells.
    Liu PS; Liaw CT; Lin MK; Shin SH; Kao LS; Lin LF
    Eur J Pharmacol; 2003 Jan; 460(1):9-17. PubMed ID: 12535854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of serotonin in the catecholamine release from the adrenal medulla.
    Sugimoto Y; Yamada J; Yoshikawa T; Nishikawa F; Noma T; Horisaka K
    Adv Exp Med Biol; 1996; 398():561-3. PubMed ID: 8906325
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic consequences of the vascular permeability of chromaffin cell transplants in CNS pain modulatory regions.
    Sagen J; Pappas GD
    Exp Neurol; 1988 Dec; 102(3):290-7. PubMed ID: 2904375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.